Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,326	2,413	1,506	881.48	591.45	1,058
Short-Term Investments	720	580	120	-	-	1,075
Trading Asset Securities	0	0.96	3.78	-	-	-
Cash & Short-Term Investments	2,046	2,994	1,630	881.48	591.45	2,133
Cash Growth	-21.85%	83.66%	84.93%	49.04%	-72.27%	97.97%
Receivables	764.36	716.77	705.79	651.49	563.36	396.49
Inventory	483.11	480.45	597.04	714.06	1,073	95.4
Prepaid Expenses	146.89	177.41	185.48	91.91	131.41	62.42
Other Current Assets	315.44	260.58	317.03	267.19	252.39	152.49
Total Current Assets	3,756	4,629	3,435	2,606	2,611	2,840
Property, Plant & Equipment	250.12	227	234.99	301.38	343.42	257.1
Long-Term Investments	4.3	4.33	4.7	5.5	5	4.5
Goodwill	1,827	1,716	1,753	1,693	1,828	958.3
Other Intangible Assets	4,566	4,756	5,418	5,794	7,152	2,195
Long-Term Deferred Tax Assets	846.17	560.25	477.83	376.25	311.1	254.92
Long-Term Deferred Charges	8.03	9.49	6.48	9.25	12.03	5.24
Other Long-Term Assets	98.77	110.15	62.76	49.64	35.81	21.22
Total Assets	11,356	12,012	11,393	10,835	12,299	6,536
Accounts Payable	152.23	77.87	102.75	90.76	100.3	26.95
Accrued Expenses	853.76	821.98	748.21	757.86	588.41	315.16
Current Portion of Long-Term Debt	1,030	31	604.95	31	46.23	249.16
Current Portion of Leases	13.94	14.78	19.45	15.94	15.76	14.46
Current Income Taxes Payable	91.14	18.76	35.07	7.72	9.61	25.2
Current Unearned Revenue	-	-	-	0.46	2.09	2.55
Other Current Liabilities	133.42	74.19	26.26	29.46	46.9	20.28
Total Current Liabilities	2,274	1,039	1,537	933.19	809.3	653.75
Long-Term Debt	4,332	6,078	5,111	5,693	6,019	1,849
Long-Term Leases	53.43	43.5	64.26	77.05	93.47	140.04
Long-Term Unearned Revenue	-	-	-	-	0.46	2.32
Long-Term Deferred Tax Liabilities	629.03	676.74	847.71	944.34	1,301	130.4
Other Long-Term Liabilities	108.91	82.05	96.3	101.6	110.73	101.15
Total Liabilities	7,397	7,919	7,656	7,750	8,333	2,876
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	4,086	3,914	3,700	3,477	3,535	2,634
Retained Earnings	442.73	1,127	878.66	733.59	830.23	1,160
Comprehensive Income & Other	-569.37	-947.14	-841.62	-1,125	-399.83	-133.83
Total Common Equity	3,959	4,094	3,737	3,086	3,965	3,660
Shareholders' Equity	3,959	4,094	3,737	3,086	3,965	3,660
Total Liabilities & Equity	11,356	12,012	11,393	10,835	12,299	6,536
Total Debt	5,429	6,167	5,800	5,817	6,174	2,252
Net Cash (Debt)	-3,383	-3,173	-4,170	-4,936	-5,583	-119.4
Net Cash Per Share	-55.60	-48.07	-57.86	-78.92	-93.53	-2.11
Filing Date Shares Outstanding	60.77	60.73	62.35	63.33	61.74	56.33
Total Common Shares Outstanding	60.74	60.63	62.26	63.21	61.63	56.17
Working Capital	1,482	3,590	1,899	1,673	1,802	2,186
Book Value Per Share	65.18	67.52	60.03	48.82	64.34	65.15
Tangible Book Value	-2,434	-2,378	-3,434	-4,401	-5,015	506.39
Tangible Book Value Per Share	-40.08	-39.22	-55.16	-69.63	-81.36	9.02
Land	73.49	71.9	70.91	68.94	64.01	47.56
Machinery	126.21	116.14	107.57	100.49	99.73	63.81
Construction In Progress	38.87	34.49	18.66	67.39	86.51	7.26
Leasehold Improvements	60.74	70.2	67.72	64.78	66.32	54.11

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q